Certis Belchim BV 已宣布已与 亨利制造有限公司 (HML) 收购所有有形和无形资产，包括知识产权，与其脂肪酸钾盐的产品组合和产品线及其在作物保护中的各种应用相关。该产品组合包括一系列目前针对葡萄树中的白粉病和葡萄孢菌的产品和配方。
此次收购加强了 Certis Belchim 在生物领域的领先地位，其一系列产品补充了其现有产品组合，并以此巩固其在澳大利亚和新西兰的现有市场地位，同时提供扩大其在北美市场地位的潜力，以及在欧洲和其他地区的注册已经获得批准。
“HML is a dynamic and innovative company that has developed a range of products targeted at important economically damaging diseases in vines and other high-value crops, but which also help growers meet the demands of modern-day food and wine production,” says Certis Belchim CEOMark Waltham. “Its portfolio and pipeline are a perfect complement to our biorational product range, and we are excited about the opportunity to build on the position that HML has established in Australia and New Zealand and look to extend this to our wider Certis Belchim territory.”